Source: Eur Respir J 2003; 21: 862-865
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hampl V., Bibova J., Povysilova V., Herget J.. Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats. Eur Respir J 2003; 21: 862-865

Member's Comments

No comment yet.

Related content which might interest you: Role of NO pathway, calcium and potassium channels in the peripheral pulmonary vascular tone in dogs Source: Eur Respir J 2001; 17: 20-26 Year: 2001 SUR1/Kir6.2 potassium channel a new actor involved in pulmonary arterial hypertension Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Molecular physiology of oxygen-sensitive potassium channels Source: Eur Respir J 2001; 18: 221-227 Year: 2001 Potassium channels in pulmonary arterial hypertension Source: Eur Respir J 2015; 46: 1167-1177 Year: 2015 Prediction of effects of calcium channel blockers (CCB) on hypoxic pulmonary hypertension (HPH) due to COPD Source: Eur Respir J 2003; 22: Suppl. 45, 268s Year: 2003 The pathophysiological roles of a voltage-gated potassium channel Kv1.5 in toluene diisocyanate-induced asthma Source: Eur Respir J 2002; 20: Suppl. 38, 29s Year: 2002 Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma Source: Eur Respir J 2011; 37: 342 Year: 2011 Stable prostacyclin analogues treprostinil and iloprost activates KCa and two-pore domain TASK-1 channels in human pulmonary artery smooth muscle cells Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Effects of duramycin on cardiac voltage-gated ion channels Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Loss of response to calcium channel blockers after long-term follow up in idiopathic pulmonary arterial hypertension Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020 Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension Source: Eur Respir J 2016; 48: 1127-1136 Year: 2016 KCNK3 channel inactivation leads to pulmonary vascular alterations in rat Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Ca2+-activated K+ channel openers cause epithelium and endothelium-dependent relaxation in pulmonary tissue Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Effect of the KCa3.1 k+ channels blocker triarylmethane-34 in a murine model of chronic asthma Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Channelopathies in bronchiectasis Source: Eur Respir Mon 2011; 52: 150-162 Year: 2011 Dehydroepiandrosterone reverses chronic hypoxia/reoxygenation-induced right ventricular dysfunction in rats Source: Eur Respir J 2012; 40: 1420-1429 Year: 2012 Role of prostaglandins, nitric oxide and potassium channel in the blunting of hypoxic pulmonary vasoconstriction in the high altitude adaptive animal – Pika Source: Eur Respir J 2005; 26: Suppl. 49, 352s Year: 2005 The potential effects of pregnancy in a patient with idiopathic pulmonary arterial hypertension responding to calcium channel blockade Source: Eur Respir J, 50 (6) 1701141; 10.1183/13993003.01141-2017 Year: 2017 Anti-proliferating effect of iptakalim, a novel KATP channel opener, in cultured rabbit pulmonary arterial smooth muscle cells Source: Eur Respir J 2005; 26: Suppl. 49, 353s Year: 2005 Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2009; 33: 1354-1360 Year: 2009